Heartflow (NASDAQ:HTFL) CEO Sells $1,928,273.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $49.57, for a total value of $1,928,273.00. Following the completion of the transaction, the chief executive officer directly owned 283,014 shares of the company’s stock, valued at $14,029,003.98. This represents a 12.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The shares were sold at an average price of $45.00, for a total value of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22.

Heartflow Trading Down 1.7%

Shares of HTFL stock traded down $0.86 on Wednesday, hitting $49.46. The stock had a trading volume of 1,616,040 shares, compared to its average volume of 1,594,796. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $54.32. The company has a fifty day moving average price of $45.96 and a two-hundred day moving average price of $34.82. The firm has a market cap of $4.30 billion, a P/E ratio of -27.03 and a beta of 2.73.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The firm had revenue of $64.08 million for the quarter. The company’s revenue was up 47.7% compared to the same quarter last year. On average, analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Institutional Trading of Heartflow

Institutional investors have recently made changes to their positions in the business. GAMMA Investing LLC boosted its stake in shares of Heartflow by 75.1% during the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after buying an additional 275 shares during the last quarter. TrueMark Investments LLC increased its position in shares of Heartflow by 1.4% in the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after acquiring an additional 379 shares during the last quarter. Strs Ohio increased its position in shares of Heartflow by 35.3% in the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after acquiring an additional 1,200 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in Heartflow during the second quarter worth about $53,000. Finally, Mayport LLC raised its holdings in Heartflow by 20.0% during the second quarter. Mayport LLC now owns 12,000 shares of the company’s stock worth $352,000 after acquiring an additional 2,000 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages have commented on HTFL. Wells Fargo & Company raised their target price on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Morgan Stanley raised their price objective on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a report on Friday, August 14th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $45.00 price objective (up from $38.00) on shares of Heartflow in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $46.25.

Heartflow Company Profile

HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.

Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient’s coronary arteries and can estimate the impact of blockages on blood flow.